Already launching in December with one of the largest series A rounds in history, Juno Therapeutics extends the venture round by a further $25m.
Juno Therapeutics, an oncology spin-out of three cancer research institutes, has extended its already sizable series A to $145m. Amazon founder Jeff Bezos’ personal investment company Bezos Expeditions joined the round along with venture firm Venrock. The two join ARCH Venture Partners, a venture firm once part of the University of Chicago, and the Alaska…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
